تاريخ الإيرادات والأرباح والتدفقات النقدية من القوائم المالية الرسمية.
Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth.
الرسوم البيانية التفاعلية والقوائم الكاملة ← نموذج التقييم (DCF) ←
| قائمة الدخل | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| إجمالي الإيرادات | $4.1B | $4.0B | $4.0B | $3.9B | $3.7B | $4.0B | $2.5B | $2.4B | $2.0B | $1.5B | $1.1B | $845M | $762M | $660M | $560M | $480M | $387M | $312M | $304M | $284M | $206M |
| إجمالي الربح | $2.8B | $2.8B | $2.8B | $2.7B | $2.6B | $2.9B | $1.8B | $1.7B | $1.4B | $1.1B | $815M | $640M | $578M | $498M | $416M | $361M | $303M | $233M | $225M | $209M | $142M |
| هامش الربح الإجمالي % | 68.1% | 68.3% | 70.0% | 70.1% | 70.5% | 74.3% | 71.3% | 72.5% | 73.6% | 75.8% | 75.5% | 75.7% | 75.9% | 75.4% | 74.4% | 75.3% | 78.4% | 74.8% | 74.1% | 73.6% | 68.6% |
| الدخل التشغيلي (EBIT) | $622M | $616M | $608M | $643M | $643M | $976M | $387M | $542M | $467M | $354M | $249M | $189M | $194M | $94M | $86M | $90M | $103M | ($34M) | $16M | $34M | ($38M) |
| هامش التشغيل % | 15.0% | 15.3% | 15.2% | 16.7% | 17.2% | 24.7% | 15.7% | 22.5% | 23.7% | 24.0% | 23.1% | 22.3% | 25.4% | 14.3% | 15.3% | 18.8% | 26.5% | -10.9% | 5.1% | 11.9% | -18.2% |
| صافي الدخل | $414M | $410M | $421M | $445M | $362M | $772M | $1.8B | $443M | $400M | $231M | $190M | $144M | $146M | $64M | $59M | $67M | $74M | ($31M) | $80M | $36M | ($35M) |
| هامش الربح الصافي % | 10.0% | 10.2% | 10.5% | 11.5% | 9.7% | 19.5% | 71.8% | 18.4% | 20.3% | 15.7% | 17.6% | 17.0% | 19.1% | 9.7% | 10.5% | 13.9% | 19.2% | -10.0% | 26.3% | 12.6% | -16.9% |
| EBITDA | — | $766M | $817M | $643M | $780M | $1.1B | $481M | $593M | $521M | $391M | $273M | $207M | $211M | $178M | $140M | $108M | $121M | ($21M) | $30M | $47M | ($27M) |
| ربحية السهم (EPS) | $5.75 | $5.65 | $5.62 | $5.81 | $4.61 | $9.69 | $22.41 | $5.53 | $4.92 | $2.83 | $2.33 | $1.77 | $1.77 | $0.78 | $0.71 | $0.83 | $0.95 | $-0.45 | $1.18 | $0.50 | $-0.55 |
| الأسهم القائمة (م) | — | 73M | 75M | 77M | 78M | 80M | 79M | 80M | 81M | 82M | 81M | 82M | 82M | 83M | 83M | 80M | 78M | 69M | 68M | 71M | 63M |
المصدر: التقارير العامة للشركة (SEC). تحقق من SEC EDGAR قبل الاعتماد على أي رقم.
الميزانيات والتدفقات النقدية والبيانات الفصلية والنسب المالية الكاملة في العارض التفاعلي لـ ALGN. /companies/us/ALGN
المعلومات في هذا الموقع لأغراض تعليمية وإعلامية فقط ولا تشكل نصيحة استثمارية. لا تُنشر أسعار مستهدفة أو توصيات.
About TickerBase · Data methodology & sources · Privacy · Terms